Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$98.98 - $115.74 $7,324 - $8,564
-74 Reduced 29.48%
177 $21,000
Q2 2023

Aug 09, 2023

SELL
$96.34 - $112.38 $30,058 - $35,062
-312 Reduced 55.42%
251 $26,000
Q1 2023

May 09, 2023

SELL
$107.32 - $113.5 $94.3 Million - $99.7 Million
-878,765 Reduced 99.94%
563 $62,000
Q4 2022

Feb 10, 2023

SELL
$62.39 - $113.8 $625,397 - $1.14 Million
-10,024 Reduced 1.13%
879,328 $100 Million
Q3 2022

Nov 09, 2022

BUY
$58.92 - $84.67 $5.81 Million - $8.34 Million
98,534 Added 12.46%
889,352 $55 Million
Q2 2022

Aug 09, 2022

SELL
$79.4 - $116.36 $6.74 Million - $9.87 Million
-84,855 Reduced 9.69%
790,818 $63.1 Million
Q1 2022

May 09, 2022

BUY
$86.42 - $109.81 $4.04 Million - $5.13 Million
46,748 Added 5.64%
875,673 $92.1 Million
Q4 2021

Feb 11, 2022

BUY
$98.56 - $119.91 $4.15 Million - $5.05 Million
42,129 Added 5.35%
828,925 $89.3 Million
Q3 2021

Nov 10, 2021

SELL
$91.91 - $110.37 $828,201 - $994,544
-9,011 Reduced 1.13%
786,796 $86.2 Million
Q2 2021

Aug 10, 2021

BUY
$86.24 - $95.92 $1.07 Million - $1.19 Million
12,436 Added 1.59%
795,807 $74.5 Million
Q1 2021

May 11, 2021

BUY
$71.83 - $95.48 $17.2 Million - $22.8 Million
238,786 Added 43.85%
783,371 $72.1 Million
Q4 2020

Feb 05, 2021

BUY
$67.0 - $84.39 $29.4 Million - $37 Million
438,670 Added 414.17%
544,585 $39.8 Million
Q3 2020

Nov 10, 2020

SELL
$55.23 - $79.93 $2.53 Million - $3.66 Million
-45,781 Reduced 30.18%
105,915 $8.23 Million
Q2 2020

Aug 06, 2020

SELL
$30.2 - $56.98 $985,516 - $1.86 Million
-32,633 Reduced 17.7%
151,696 $8.43 Million
Q1 2020

May 11, 2020

SELL
$24.87 - $38.56 $258,623 - $400,985
-10,399 Reduced 5.34%
184,329 $5.46 Million
Q4 2019

Feb 10, 2020

BUY
$25.43 - $36.67 $4.95 Million - $7.14 Million
194,728 New
194,728 $7.05 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.